Literature DB >> 8844981

Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer.

N Okada1, A Kubota, T Imamura, H Suwa, Y Kawaguchi, G Ohshio, Y Seino, M Imamura.   

Abstract

The brain-gut hormones, cholecystokinin (CCK) and gastrin, regulate the growth of gastrointestinal mucosa and tumor cells. In this study, reverse transcription-polymerase chain reaction (RT-PCR) was used to evaluate messenger RNA expression for CCK, gastrin, CCK-A receptor, and CCK-B/gastrin receptor in surgical specimens of gastric cancers and in normal antrum and body mucosa of the stomach. The CCK mRNA expression was detectable in 4/14 (29%) samples of gastric cancer and in 3/12 (25%) samples of antral mucosa. However, the gastrin mRNA expression was not detectable in any gastric cancer samples, although it was detectable in all the samples of antral mucosa. The CCK-A receptor mRNA expression was detectable in 5/14 (36%) samples of gastric cancer and in 7/12 (58%) body mucosa. Three cases out of 14 (21%) of gastric cancer expressed both CCK gene and CCK-A receptor gene. The CCK-B receptor mRNA expression was detectable in only 1/14 (7%) samples of gastric cancer, although it was detectable in 10/12 (83%) body mucosa of the stomach. These findings may suggest a greater role for CCK and CCK-A receptor than for gastrin and CCK-B receptor in gastric cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844981     DOI: 10.1016/0304-3835(96)04325-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Long-term effects of proglumide on resection of cardiac adenocarcinoma.

Authors:  Yu-Ping Chen; Jie-Sheng Yang; Di-Tian Liu; Wei-Ping Yang
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

2.  Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats.

Authors:  Xiao-Yun Zhao; Yi-Ling Ling; Yu-Guang Li; Ai-Hong Meng; Han-Ying Xing
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

3.  Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression.

Authors:  Lydia E Wroblewski; David M Pritchard; Stuart Carter; Andrea Varro
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 4.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

5.  Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.

Authors:  Martin Béhé; Wolfgang Becker; Martin Gotthardt; Christa Angerstein; Thomas M Behr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-24       Impact factor: 9.236

6.  Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma.

Authors:  Liang Zhao; Zhi-Xiang Shen; He-Sheng Luo; Lei Shen
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

7.  Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease?

Authors:  Hasan Raza Kazmi; Abhijit Chandra; Kavita Baghel; Anshuman Singh; Jaya Nigam; Devendra Parmar; Abbas Ali Mahdi; Sudhir K Goel; Sandeep Kumar
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

8.  High expression of proenkephalin is associated with favorable outcomes in patients with gastrointestinal stromal tumors.

Authors:  Defeng Tang; Tianlong Lin; Yangyang Wang; Hui Cao
Journal:  Cancer Manag Res       Date:  2019-07-17       Impact factor: 3.989

Review 9.  Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.

Authors:  Qiang Zeng; Lei Ou; Wei Wang; Dong-Yu Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.